Literature DB >> 28843488

Objective Measures of Psoriasis Severity Predict Mortality: A Prospective Population-Based Cohort Study.

Megan H Noe1, Daniel B Shin2, Marilyn T Wan2, Joel M Gelfand3.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28843488      PMCID： PMC6748628          DOI： 10.1016/j.jid.2017.07.841

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  13 in total

1.  Mortality and causes of death among psoriatics.

Authors:  B Lindegård
Journal:  Dermatologica       Date:  1989

2.  Nationwide population-based study of cause-specific death rates in patients with psoriasis.

Authors:  E Salahadeen; C Torp-Pedersen; G Gislason; P R Hansen; O Ahlehoff
Journal:  J Eur Acad Dermatol Venereol       Date:  2014-06-09       Impact factor: 6.166

3.  Excess mortality related to alcohol and smoking among hospital-treated patients with psoriasis.

Authors:  K Poikolainen; J Karvonen; E Pukkala
Journal:  Arch Dermatol       Date:  1999-12

4.  Very severe psoriasis is associated with increased noncardiovascular mortality but not with increased cardiovascular risk.

Authors:  Robert S Stern; Annemieke Huibregtse
Journal:  J Invest Dermatol       Date:  2011-01-20       Impact factor: 8.551

5.  Increased cause-specific mortality in patients with mild and severe psoriasis: a population-based Swedish register study.

Authors:  Axel Svedbom; Johan Dalén; Carla Mamolo; Joseph C Cappelleri; Lotus Mallbris; Ingemar F Petersson; Mona Ståhle
Journal:  Acta Derm Venereol       Date:  2015-09       Impact factor: 4.437

6.  Psoriasis severity and the prevalence of major medical comorbidity: a population-based study.

Authors:  Howa Yeung; Junko Takeshita; Nehal N Mehta; Stephen E Kimmel; Alexis Ogdie; David J Margolis; Daniel B Shin; Rosemary Attor; Andrea B Troxel; Joel M Gelfand
Journal:  JAMA Dermatol       Date:  2013-10       Impact factor: 10.282

7.  Risk of mortality in patients with psoriatic arthritis, rheumatoid arthritis and psoriasis: a longitudinal cohort study.

Authors:  Alexis Ogdie; Kevin Haynes; Andrea B Troxel; Thorvardur Jon Love; Sean Hennessy; Hyon Choi; Joel M Gelfand
Journal:  Ann Rheum Dis       Date:  2012-12-21       Impact factor: 19.103

8.  The risk of mortality in patients with psoriasis: results from a population-based study.

Authors:  Joel M Gelfand; Andrea B Troxel; James D Lewis; Shanu Kohli Kurd; Daniel B Shin; Xingmei Wang; David J Margolis; Brian L Strom
Journal:  Arch Dermatol       Date:  2007-12

9.  Adaptation and validation of the Charlson Index for Read/OXMIS coded databases.

Authors:  Nada F Khan; Rafael Perera; Stephen Harper; Peter W Rose
Journal:  BMC Fam Pract       Date:  2010-01-05       Impact factor: 2.497

10.  Incidence, prevalence and mortality of patients with psoriasis: a U.K. population-based cohort study.

Authors:  D A Springate; R Parisi; E Kontopantelis; D Reeves; C E M Griffiths; D M Ashcroft
Journal:  Br J Dermatol       Date:  2016-12-22       Impact factor: 9.302
View more
  8 in total

1.  Commentary: Does biologic treatment of psoriasis lower the risk of cardiovascular events and mortality?: A critical question that we are only just beginning to answer.

Authors:  Joel M Gelfand
Journal:  J Am Acad Dermatol       Date:  2018-04-03       Impact factor: 11.527

2.  Updates in Psoriasis Management: Based on selected presentations from Maui Derm 2020, January 25-29, 2020, Maui, Hawaii.

Authors:  Jo Ann Lequang
Journal:  J Clin Aesthet Dermatol       Date:  2020-07-01

3.  Psoriasis and the risk of diabetes: A prospective population-based cohort study.

Authors:  Marilyn T Wan; Daniel B Shin; Rebecca A Hubbard; Megan H Noe; Nehal N Mehta; Joel M Gelfand
Journal:  J Am Acad Dermatol       Date:  2017-11-08       Impact factor: 11.527

4.  A Randomized Placebo-Controlled Trial of Secukinumab on Aortic Vascular Inflammation in Moderate-to-Severe Plaque Psoriasis (VIP-S).

Authors:  Joel M Gelfand; Daniel B Shin; Kristina Callis Duffin; April W Armstrong; Andrew Blauvelt; Stephen K Tyring; Alan Menter; Scott Gottlieb; Benjamin N Lockshin; Eric L Simpson; Farid Kianifard; Rajendra Prasad Sarkar; Elisa Muscianisi; Jennifer Steadman; Mark A Ahlman; Martin P Playford; Aditya A Joshi; Amit K Dey; Thomas J Werner; Abass Alavi; Nehal N Mehta
Journal:  J Invest Dermatol       Date:  2020-02-21       Impact factor: 8.551

Review 5.  New Frontiers in Psoriatic Disease Research, Part II: Comorbidities and Targeted Therapies.

Authors:  Di Yan; Andrew Blauvelt; Amit K Dey; Rachel S Golpanian; Samuel T Hwang; Nehal N Mehta; Bridget Myers; Zhen-Rui Shi; Gil Yosipovitch; Stacie Bell; Wilson Liao
Journal:  J Invest Dermatol       Date:  2021-04-19       Impact factor: 7.590

6.  Building a Citizen Pscientist: Advancing Patient-Centered Psoriasis Research by Empowering Patients as Contributors and Analysts.

Authors:  Isabelle M Sanchez; Lindsey Shankle; Marilyn T Wan; Ladan Afifi; Jashin J Wu; Frank Doris; Alisha Bridges; Marc Boas; Brian Lafoy; Sarah Truman; Ana-Maria Orbai; Junko Takeshita; Joel M Gelfand; April W Armstrong; Michael P Siegel; Wilson Liao
Journal:  Dermatol Ther (Heidelb)       Date:  2018-06-06

7.  Promises and pitfalls in implementation science from the perspective of US-based researchers: learning from a pre-mortem.

Authors:  Rinad S Beidas; Shannon Dorsey; Cara C Lewis; Aaron R Lyon; Byron J Powell; Jonathan Purtle; Lisa Saldana; Rachel C Shelton; Shannon Wiltsey Stirman; Meghan B Lane-Fall
Journal:  Implement Sci       Date:  2022-08-13       Impact factor: 7.960

8.  National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic Disease During the Pandemic: Version 1.

Authors:  Joel M Gelfand; April W Armstrong; Stacie Bell; George L Anesi; Andrew Blauvelt; Cassandra Calabrese; Erica D Dommasch; Steve R Feldman; Dafna Gladman; Leon Kircik; Mark Lebwohl; Vincent Lo Re; George Martin; Joseph F Merola; Jose U Scher; Sergio Schwartzman; James R Treat; Abby S Van Voorhees; Christoph T Ellebrecht; Justine Fenner; Anthony Ocon; Maha N Syed; Erica J Weinstein; Jessica Smith; George Gondo; Sue Heydon; Samantha Koons; Christopher T Ritchlin
Journal:  J Am Acad Dermatol       Date:  2020-09-04       Impact factor: 15.487
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.